Placental mesenchymal dysplasia: Key clinical and pathology features to aid in differentiation from molar pregnancy a case report

Published

Journal Article

© Journal of Reproductive Medicine®, Inc. BACKGROUND: Placental mesenchymal dysplasia (PMD) is a rare placental disorder characterized by placentomegaly. It carries a high incidence of adverse fetal outcomes, and its ultrasound appearance is similar to a partial hydatidiform mole and a complete hydatidiform mole with a normal co-twin. Diagnosis is made through placental pathologic examination following delivery, though prenatal testing and serial ultrasound examinations can suggest PMD over molar pregnancy. There are no consensus guidelines for antenatal and intrapartum management of PMD. CASE: A 22-year-old woman, gravida 3 para 2002, presented with an enlarged, cystic placenta with a normally grown, viable fetus. Laboratory test results were significant for a normal β-hCG, chest radiograph, and karyotype. The patient was managed with serial growth ultrasound examinations and biophysical profiles. Care was coordinated with a multidisciplinary team. She had a spontaneous vaginal delivery of a viable male infant at 366/7 weeks’ gestation. The workup for Beckwith-Wiedemann syndrome was negative. The diagnosis of PMD was made based on the gross and microscopic pathologic appearance of the placenta. CONCLUSION: PMD should be on the differential di-agnosis when placentomegaly is present on ultrasound. PMD is distinguished from hydatidiform mole based on genetic screening, as well as gross and microscopic examination of the placenta.

Duke Authors

Cited Authors

  • Kisby, CK; Bean, SM; Kuller, JA; Rhee, E

Published Date

  • June 1, 2019

Published In

Volume / Issue

  • 64 / 3

Start / End Page

  • 229 - 232

International Standard Serial Number (ISSN)

  • 0024-7758

Citation Source

  • Scopus